Scott Breidbart, MD, MBA, chief clinical officer of EmblemHealth, explained that paying patients for adherence could be efficient when the payment initiatives are targeted towards members who have not shown to be adherent; however, he added that there are several limitations in paying for adherence, including the sustainability of the system and whether it will incentivize patients who are adherent to stop taking their medications.
Scott Breidbart, MD, MBA, chief clinical officer of EmblemHealth, explained that paying patients for adherence could be efficient when the payment initiatives are targeted towards members who have not shown to be adherent; however, he added that there are several limitations in paying for adherence, including the sustainability of the system and whether it will incentivize patients who are adherent to stop taking their medications.
Transcript (slightly modified)
What sort of payment models exist right now at EmblemHealth?
Right now, we, and other plans, pay physicians in certain circumstances. So there are metrics by which the plans are judged and those metrics, HEDIS measures, are ones that we can sometimes also judge a physician or a physician group on. So we may say to the physician group, if you have a certain number of diabetics and the percentage of diabetics who gets an A1c during this year is above 80%, we’ll pay you X dollars to the diabetic who gets it done. If it’s above 90%, we’ll pay you this much more dollars for each patient who gets the hemoglobin A1c. So that is being done.
What are the concerns about paying for adherence?
There is a concern that when the payments stop, not only does the adherence go down but there may even be a further decrement. The studies are not clear on how much paying for adherence helps, and the studies are also not all that certain on whether or not after the payments stop, the reduction in adherence is beyond the baseline. So that is a concern.
There’s also the moral hazard concern is do you pay everyone for adherence? Or do you only pay the people who haven’t been shown to adhere? Which would be a more efficient way of doing it but of course then is an incentive for people not to adhere.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen